Relief for her,
with you in mind.

Minimize pain points for both of you. For her, Cerene® is a well-tolerated and effective heavy menstrual bleeding treatment that doesn't limit future diagnostic options. For you, it's an efficient solution designed for your office.
Introducing Cerene® Cryotherapy

With 1 in 3 women seeking treatment annually1, heavy menstrual bleeding negatively affects womens’ physical, social, and emotional well-being. Cerene can help change that.

The Cerene Cryotherapy Device is FDA approved for safe and effective in-office endometrial cryoablation.
Cerene delivers an all-around solution for you and your patients.

High Patient Satisfaction
A well-tolerated treatment that significantly reduces both heavy menstrual bleeding and dysmenorrhea, improving quality of life
Efficient In-Office Treatment
A treatment designed to fit into your office routine with no general anesthesia or capital equipment required
Preserved Cavity Access
Easily access the uterine cavity post-ablation for future diagnostic evaluations
Learn more about Cerene
Real Patient Results
had normal, light or no periods†
were satisfied with Cerene†
uterine cavity visualization at 1 year post treatment
hysterectomy for HMB over 3 years
See the Clinical Outcomes

† Patient-reported data are 1 year after treatment with durable results at 3 years

What Your Peers Are Saying
Cerene has the potential to be a real game-changer. Cerene is an effective, safe, and easy-to-use endometrial cryoablation procedure that can be performed without general anesthesia.
Dr. Todd Rumsey, Chief Medical Officer
Cameron Memorial Community Hospital
Cerene Training

Interested in offering Cerene to your patients?
Learn more about our training program to get you started.

Get Cerene Training

1. The American College of Obstetricians and Gynecologists. FAQ May 2021.
https://www.acog.org/Patients/FAQs/Heavy-Menstrual-Bleeding?IsMobileSet=false

Important Safety Information

Cerene® Cryotherapy Device is indicated to ablate the endometrial lining of the uterus in premenopausal women with heavy menstrual bleeding due to benign causes for whom childbearing is complete. Pregnancy following the Cerene procedure can be dangerous; therefore, contraception must be used until menopause. The Cerene procedure is not for those who have or suspect uterine cancer; have an active genital, urinary or pelvic infection; or an IUD. There are risks and considerations associated with the use of the Cerene Cryotherapy Device. Temporary side effects may include uterine cramping, vaginal infection, and lightheadedness. For detailed benefit and risk information, consult the Cerene Instructions for Use (IFU) or your healthcare professional. CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician trained in the use of the Cerene Cryotherapy Device. Learn More